Published: 2017-01-12

A comparative study of efficacy and safety of flupirtine versus piroxicamin patients with low back pain

Ambrish Sharma, Manjunath SM, Nagesh Raju G, Dharmaraj B, Nagendra Gowda MR


Background: Low back pain is a common musculoskeletal symptom caused by a variety of disorders that affect the lumbar spine. The most frustrating aspect in the treatment of low back pain is that there is “no magic bullets”. The objective of the study was to compare the efficacy and safety of flupirtine versus piroxicam in patients with back pain.

Methods: This was prospective, open labeled, randomized, comparative clinical study conducted by the Departments Orthopedics and Pharmacology, BMC&H, Chitradurga. Study was conducted on 60 patients of either sex, aged above 18 years with low back pain. Assessments were done for Finger-to-Floor Distance (FFD), lumbar pain, Lasegue’s sign, tenderness of vertebral muscles, pain & sensory disturbance in lower limbs and response to therapy for efficacy. Parametric data was analyzed by t-test and proportions were compared using Chi-square test.

Results: 74 patients were randomized to 2 groups of 37 each. Group I patients received flupirtine maleate 100 mg twice daily and Group II patients received piroxicam 20 mg twice daily for 14 days. 30 patients in each group completed the study and were analysed. On intergroup comparison, there was no statistical difference (p>0.05) in the efficacy parameters of finger-to-floor distance (FFD), lumbar pain, Lasegue’s sign, tenderness of vertebral muscles, sensory disturbance in lower limbs, VAS scores & global assessment of response to therapy. 13.3% in flupirtine group and 16.6% in piroxicam group reported adverse events.  

Conclusions: Both flupiritine and piroxicam were equally effective but flupirtine was better tolerated than piroxicam.



Flupirtine, Piroxicam, Low back pain

Full Text:



Doherty M, Laryon P, Ralston SH. Presenting problems in musculoskeletal diseases; back & neck pain. In: Boon NA, Colledge NR, Walker BR, eds. Davidson’s: the Principle & Practice of Medicine. 20th ed. London: Churchill Livingstone, Elsevier; 2006: 1083-1084.

Panchapakesa RC. Low back pain. In: Shah SN, Paul AN, eds. API Text book of Medicine. 7th ed. Mumbai: The Association of Physician of India; 2007: 1148-1151.

Chandanwale AS, Chopra A, Goregaonkar A, Medhi B, Shah V, Gaikwad S, et al. Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial. J Postgrad Med. 2011;57:278-85.

Roelofs PDDM, Rick Deyo A, Bart WK, Rob JPMS, Maurits Wran Tulder. Non-steroidal anti-inflammatory drugs for low back pain. The Cochrane Collabor (John Wiley & Sons Ltd). 2011;2:1-85.

Rikki S, Praveen G, Samita G. Role of flupirtine in treatment of pain-chemistry & its effects. Maedica (Buchar.) 2012;7:163-6.

Harish S, Bhuvana K, Kumar TN. Flupirtine: clinical pharmacology. J Anaesthesiol Clin Pharmacol. 2012;28:172-7.

Arul Prakasam KC, Salman P, Senthilkumar N. Comparative assessment of analgesic effect of different NSAID’s in the management of low back pain. Int J Pharm Tech Res. 2011;3:1260-4.

Hanai K, Inoue Y, Itoh Y, Satake T. Clinical experience of eperisone hydrochloride in patients with lumbago. J Clin Exp Med. 1983;60:2049-53.

Manasi Banerjee, Kuntal Bhattacharyya, Rathindra Nath Sarkar, Balaram Ghosh. Comparative study of efficacy and tolerability of flupirtine versus tramadol in non-steroidal anti-inflammatory drug intolerant mechanical low back pain. Indian J Rheum. 2012;7:135-40.

Amlie E, Weber H, Holme I. Treatment of acute low-low back pain with piroxicam: results of a double-blind placebo-controlled trial. Spine. 1987;12:473-6.

Joginder Pal Attri, Gagandeep Kaur Sandhu, Sudhir Khichy, Harsimrat Singh, Kulwinder Singh, Radhe Sharan. Comparative evaluation of oral flupirtine and oral diclofenac sodium for analgesia and adverse effects in elective abdominal surgeries. Anesth Essays Res. 2015;9:72-8.